ExpreS2ion Biotech Holding AB
STO:EXPRS2
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
15.18
30.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
EXPRS2 Price Targets Summary
ExpreS2ion Biotech Holding AB
According to Wall Street analysts, the average 1-year price target for EXPRS2 is 76.5 SEK with a low forecast of 75.75 SEK and a high forecast of 78.75 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EXPRS2's stock price target?
Price Target
76.5
SEK
According to Wall Street analysts, the average 1-year price target for EXPRS2 is 76.5 SEK with a low forecast of 75.75 SEK and a high forecast of 78.75 SEK.
What is ExpreS2ion Biotech Holding AB's Revenue forecast?
Projected CAGR
221%
The compound annual growth rate of ExpreS2ion Biotech Holding AB's revenue for the next 3 years is 221%.
